CLASS II Drug recall · Reported 10 Sep 2014 · FDA Enforcement Report

Paroxetine HCL Controlled-Release Tablets 5 mg recalled by Apotex

Apotex is recalling Paroxetine HCL Controlled-Release Tablets 5 mg, distributed nationwide in the US. The recall was initiated on 24 Mar 2014 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # 2C002, Exp. 03/15 Lot # 2H004, Exp. 08/15 Lot # 2H006, Exp. 08/15
NDC60505-1316, 60505-1317, 60505-1318, 60505-3673, 60505-3674, 60505-3675
UPC0360505367436, 0360505367535, 0360505367337

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1577-2014
FDA event ID
68967
Recalling firm
Apotex, Toronto
Manufacturer
Apotex Corp
Classification
Class II
Status
Terminated
Recall initiated
24 Mar 2014
FDA classified
3 Sep 2014
Reported
10 Sep 2014
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons
Drug class
Antidepressants

Timeline

24 Mar 2014Recall initiated by company
3 Sep 2014Classified by FDA+163 days
10 Sep 2014Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.

Product as listed by the FDA

Paroxetine HCL Controlled-Release Tablets 37.5 mg, 30-count bottle, Rx only, Manufactured by GlaxoSmithKline, RTP, NC 27709, Manufactured for Apotex Corp., Weston, FL 33328, NDC 60505-3675-3

Where it was distributed

Nationwide and Puerto Rico

Nationwide Puerto Rico

Questions about this recall

Is Paroxetine HCL Controlled-Release Tablets 5 mg recalled?

Yes. Apotex recalled Paroxetine HCL Controlled-Release Tablets 5 mg on 24 Mar 2014. The recall is Class II and its status is Terminated. Recall number D-1577-2014.

Why was it recalled?

Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.

Which lots are affected?

Lot # 2C002, Exp. 03/15 Lot # 2H004, Exp. 08/15 Lot # 2H006, Exp. 08/15

Where was it sold?

Nationwide and Puerto Rico

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Apotex

All 75
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIPaxil CR, Paroxetine, Extended-Release Tablets, 5mg recalled by ApotexApotexPotency & AssayNationwide
DrugCLASS IIDesmopressin Nasal Spray, USP, 10 mcg/ bottle (50 doses) recalledApotexOtherNationwide
DrugCLASS IIBrimonidine Tartrate/Timolol Maleate Ophthalmic Solution 2%/0.5%* recalledBrimonidine Tartrate/timolol Maleate Ophthalmic SolutionApotexSterilityNationwide
DrugCLASS IIKetorolac Tromethamine Ophthalmic Solution recalled by ApotexKetorolac TromethamineApotexSterilityNationwide
DrugCLASS IIBrimonidine Tartrate/Timolol Maleate Ophthalmic Solution recalledBrimonidine Tartrate/timolol Maleate Ophthalmic SolutionApotexSterilityNationwide

Other Paroxetine recalls

All 16